{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-102052","form_type":"8-K","ticker":null,"cik":"0001872356","company_name":"Molekule Group, Inc.","filed_at":"2023-09-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.946217+00:00","generated_at":"2026-06-10T12:36:18.003290+00:00","sec_items":["2.05","5.02","8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"Molekule Group prepares Chapter 11 filing after lease settlement failure; cuts workforce 15%","bullets":["Workforce reduction of ~15% with non-recurring costs of $150k-$200k in severance, expected Q3 2023.","COO Ritankar Ronti Pal resigned effective Sept 19, 2023 for personal reasons.","Failed to reach settlement with legacy lease landlord; landlord will file civil complaint, seek to attach cash accounts, triggering SVB default.","Board authorized preparation of voluntary Chapter 11 petition; bankruptcy counsel engaged.","Rights offering on Form S-1 withdrawn; company will not proceed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-102052","json":"https://secwatch.observer/filing/0001104659-23-102052.json","markdown":"https://secwatch.observer/filing/0001104659-23-102052.md","text":"https://secwatch.observer/filing/0001104659-23-102052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923102052/0001104659-23-102052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923102052/tm2325347d5_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T12:36:18.003290+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d8ef84fc68","claim":"Ritankar Ronti Pal resigned as Chief Operating Officer at Molekule Group, Inc..","evidence_excerpt":"On September 19, 2023, Ritankar Ronti Pal, the Chief Operating Officer of the Company, resigned from all positions at the Company, effective as of September 19, 2023, due to personal reasons.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923102052/0001104659-23-102052-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"7943c278988f4a6664e724d4bcabc6b1ab2affa3","claim":"Molekule Group, Inc. announced a restructuring with charges of approximately $150,000 to $200,000 (approximately 15%).","evidence_excerpt":"Reduction is part of the Company’s cost-reduction efforts intended to reduce operating expenses. The Company expects that it will incur non-recurring costs of approximately $150,000 to $200,000 as a result of this action, principally in severance expenses. The Company expects that the majority of these costs will be incurred in the third quarter of 2023 and","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923102052/0001104659-23-102052-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $150,000 to $200,000"},{"label":"Headcount","value":"approximately 15%"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}